These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32300292)

  • 1. Cerebellar Development and Circuit Maturation: A Common Framework for Spinocerebellar Ataxias.
    Binda F; Pernaci C; Saxena S
    Front Neurosci; 2020; 14():293. PubMed ID: 32300292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Cerebellar Circuitry in the Spinocerebellar Ataxias.
    Robinson KJ; Watchon M; Laird AS
    Front Neurosci; 2020; 14():707. PubMed ID: 32765211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
    Kasumu A; Bezprozvanny I
    Cerebellum; 2012 Sep; 11(3):630-9. PubMed ID: 20480274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).
    Prestori F; Moccia F; D'Angelo E
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterotopic Purkinje Cells: a Comparative Postmortem Study of Essential Tremor and Spinocerebellar Ataxias 1, 2, 3, and 6.
    Louis ED; Kuo SH; Tate WJ; Kelly GC; Gutierrez J; Cortes EP; Vonsattel JG; Faust PL
    Cerebellum; 2018 Apr; 17(2):104-110. PubMed ID: 28791574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Neurodegenerative Spinocerebellar Ataxia Type 13 in Zebrafish Using a Purkinje Neuron Specific Tunable Coexpression System.
    Namikawa K; Dorigo A; Zagrebelsky M; Russo G; Kirmann T; Fahr W; Dübel S; Korte M; Köster RW
    J Neurosci; 2019 May; 39(20):3948-3969. PubMed ID: 30862666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Exploration of preventive drugs for spinocerebellar ataxia using cultured cerebellar Purkinje cells].
    Seki T
    Nihon Yakurigaku Zasshi; 2019; 154(6):310-314. PubMed ID: 31787682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review.
    Park JY; Joo K; Woo SJ
    Front Neurosci; 2020; 14():892. PubMed ID: 32973440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6.
    Jayabal S; Ljungberg L; Watt AJ
    J Physiol; 2017 Feb; 595(3):949-966. PubMed ID: 27531396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and circuit mechanisms underlying spinocerebellar ataxias.
    Meera P; Pulst SM; Otis TS
    J Physiol; 2016 Aug; 594(16):4653-60. PubMed ID: 27198167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
    Shimobayashi E; Kapfhammer JP
    Curr Neuropharmacol; 2018 Jan; 16(2):151-159. PubMed ID: 28554312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14.
    Ji J; Hassler ML; Shimobayashi E; Paka N; Streit R; Kapfhammer JP
    Neurobiol Dis; 2014 Oct; 70():1-11. PubMed ID: 24937631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain pathology of spinocerebellar ataxias.
    Seidel K; Siswanto S; Brunt ER; den Dunnen W; Korf HW; Rüb U
    Acta Neuropathol; 2012 Jul; 124(1):1-21. PubMed ID: 22684686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Key Role of the mGluR1-PKCγ Signaling Pathway in the Pathogenesis of Spinocerebellar Ataxias: A Neurodevelopmental Viewpoint.
    Wu QW; Kapfhammer JP
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological Disease Modelling for Spinocerebellar Ataxia Using Zebrafish.
    Namikawa K; Dorigo A; Köster RW
    J Exp Neurosci; 2019; 13():1179069519880515. PubMed ID: 31666796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
    Matilla-Dueñas A; Sánchez I; Corral-Juan M; Dávalos A; Alvarez R; Latorre P
    Cerebellum; 2010 Jun; 9(2):148-66. PubMed ID: 19890685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.
    Corral-Juan M; Serrano-Munuera C; Rábano A; Cota-González D; Segarra-Roca A; Ispierto L; Cano-Orgaz AT; Adarmes AD; Méndez-Del-Barrio C; Jesús S; Mir P; Volpini V; Alvarez-Ramo R; Sánchez I; Matilla-Dueñas A
    Brain; 2018 Jul; 141(7):1981-1997. PubMed ID: 29939198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.
    Gómez-Ruiz M; Rodríguez-Cueto C; Luna-Piñel E; Hernández-Gálvez M; Fernández-Ruiz J
    Front Mol Neurosci; 2019; 12():94. PubMed ID: 31068788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keeping Our Calcium in Balance to Maintain Our Balance.
    Mark MD; Schwitalla JC; Groemmke M; Herlitze S
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1040-1050. PubMed ID: 27392710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.
    Bushart DD; Murphy GG; Shakkottai VG
    Ann Transl Med; 2016 Jan; 4(2):25. PubMed ID: 26889478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.